5-69433088-C-T
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The ENST00000325631.10(MARVELD2):c.1498C>T(p.Arg500Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00027 in 1,612,640 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
ENST00000325631.10 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MARVELD2 | NM_001038603.3 | c.1498C>T | p.Arg500Ter | stop_gained | 5/7 | ENST00000325631.10 | NP_001033692.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MARVELD2 | ENST00000325631.10 | c.1498C>T | p.Arg500Ter | stop_gained | 5/7 | 1 | NM_001038603.3 | ENSP00000323264 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000860 AC: 13AN: 151152Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000995 AC: 25AN: 251192Hom.: 0 AF XY: 0.000110 AC XY: 15AN XY: 135792
GnomAD4 exome AF: 0.000289 AC: 423AN: 1461488Hom.: 0 Cov.: 34 AF XY: 0.000260 AC XY: 189AN XY: 727060
GnomAD4 genome AF: 0.0000860 AC: 13AN: 151152Hom.: 0 Cov.: 32 AF XY: 0.0000136 AC XY: 1AN XY: 73636
ClinVar
Submissions by phenotype
Autosomal recessive nonsyndromic hearing loss 49 Pathogenic:5
Pathogenic, criteria provided, single submitter | clinical testing | Victorian Clinical Genetics Services, Murdoch Childrens Research Institute | May 06, 2021 | Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with Deafness 49 (MIM#610153). (I) 0106 - This gene is associated with autosomal recessive disease. (I) 0201 - Variant is predicted to cause nonsense-mediated decay (NMD) and loss of protein (premature termination codon is located at least 54 nucleotides upstream of the final exon-exon junction). (SP) 0252 - This variant is homozygous. (I) 0304 - Variant is present in gnomAD (v2) <0.01 for a recessive condition (26 heterozygotes, 0 homozygotes). (SP) 0701 - Many NMD predicted variants comparable to the one identified in this case have very strong previous evidence for pathogenicity (ClinVar, PMID: 23767834, 33597575). (SP) 0801 - This variant has strong previous evidence of pathogenicity in unrelated individuals. This variant has been previously reported as pathogenic in individuals with hearling loss (ClinVar, PMID: 17186462, 31850270) (SP) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Dec 01, 2006 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Genomic Research Center, Shahid Beheshti University of Medical Sciences | Aug 07, 2018 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Jul 29, 2023 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Nov 30, 2018 | The MARVELD2 c.1498C>T (p.Arg500Ter) variant is a stop-gained variant that is predicted to result in a premature termination of the protein. The p.Arg500Ter variant is reported in a homozygous state in eight individuals from one family with nonsyndromic hearing loss (Riazuddin et al. 2006). The p.Arg500Ter variant was shown to segregate with the disease and was absent from 443 normal hearing subjects matched for ethnicity. The p.Arg500Ter variant is reported at a frequency of 0.00024 in the European (non-Finnish) population of the Exome Aggregation Consortium. Functional studies showed that the p.Arg500Ter variant disrupts the binding of the occludin domain to the scaffolding protein ZO-1 (Riazuddin et al. 2006). Nayak et al. (2013) generated knockin mice that were homozygous for the p.Arg500Ter variant and demonstrated ultrastructural changes in the tricellular junctions in all sensory and nonsensory epithelia of the inner ear organs and cochlear hair cell loss. Vax-Drago et al. (2015) demonstrated that, in a cell line derived from an individual who was homozygous for the p.Arg500Ter variant, total cellular mRNA levels were reduced compared to wild type, especially in the cytoplasmic fraction. Based on the evidence and the potential impact of stop-gained variants, the p.Arg500Ter variant is classified as pathogenic for autosomal recessive nonsyndromic hearing loss. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jan 27, 2023 | Published functional studies demonstrate that this variant results in disrupted MARVELD2 ZO-1 binding capacity, mislocalization of the protein from the tricellular junctions, and non-specific targeting of the mutant protein to basolateral domains of transfected cells (Nayak et al., 2013; Nayak et al., 2015); Nonsense variant in the C-terminus predicted to result in protein truncation, and other loss-of-function variants have been reported downstream in the Human Gene Mutation Database (HGMD); This variant is associated with the following publications: (PMID: 17186462, 25666562, 25652404, 25525159, 28705832, 29752989, 30406641, 31850270, 31589614, 26226137, 23979167) - |
Rare genetic deafness Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jun 19, 2014 | The p.Arg500X variant in MARVELD2 has been previously reported in one individual with hearing loss and segregated with disease in 7 affected relatives from one family (Riazuddin 2006). It has also been identified in 0.018% (23/126596) of E uropean chromosomes by gnomAD (http://gnomad.broadinstitute.org). This nonsense variant creates a premature termination codon at position 500 and is predicted t o lead to a truncated or absent protein. Functional and animal studies support t he pathogenicity of the p.Arg500X variant (Riazuddin 2006, Nayak 2013). In summa ry, this variant meets criteria to be classified as pathogenic for autosomal rec essive sensorineural hearing loss. ACMG/AMP Criteria applied: PM3_Supporting, P P1_Strong, PVS1, PS3. - |
Ear malformation Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Kariminejad - Najmabadi Pathology & Genetics Center | Jul 10, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at